Comments
Loading...
OS Therapies (OSTX) Forecast
NewsEarningsOS Therapies (OSTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOS Therapies (AMEX:OSTX) Stock Quotes, Forecast and News Summary
OS Therapies Stock (AMEX: OSTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy OS Therapies (OSTX) stock?
You can purchase shares of OS Therapies (AMEX:OSTX) through any online brokerage.
Who are OS Therapies (OSTX) competitors?
Other companies in OS Therapies’s space includes: Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Gain Therapeutics (NASDAQ:GANX), OncoCyte (NASDAQ:OCX) and Intensity Therapeutics (NASDAQ:INTS).
What is the forecast, or price target, for OS Therapies (OSTX) stock?
OS Therapies has a consensus price target of $21.00.
What is the current price for OS Therapies (OSTX)?
The stock price for OS Therapies (AMEX: OSTX) is $2.1889 last updated November 15, 2024 at 1:59 PM EST.
Does OS Therapies (OSTX) pay a dividend?
There are no upcoming dividends for OS Therapies.
When is OS Therapies (AMEX:OSTX) reporting earnings?
OS Therapies’s Q4 earnings are confirmed for Saturday, February 15, 2025.
Is OS Therapies (OSTX) going to split?
There is no upcoming split for OS Therapies.
What sector and industry does OS Therapies (OSTX) operate in?
OS Therapies is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.